The Lantz Family
#carolinestrong
November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma; Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease; April 2019-April 2021: enrolled in/completed DFMO clinical trial; April 2022: RELAPSE; April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again); June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial; June 2024: RELAPSE #2
On this exact day - Black Friday, November 24, 2017, Caroline was diagnosed with Stage IV, High-Risk Neuroblastoma. 6 years later, November 24, 2023, another Black Friday, we took a drive down to the hospital for the annual "Snowman picture."
Caroline was discharged from Vanderbilt on Saturday and is now home resting. Other than the "normal" nausea and belly pain, the week was relatively uneventful. She will get daily Leukine shots for the next week to help bring up her neutrophils (immune system). We're hoping she recovers well at home, and is able to enjoy the next two weeks of "track out break" from school.
This coming Saturday (3/25), Caroline will be speaking as an ambassador for the hospital at the "Clip !n 4 the Cure" event, which raises funds for cancer research to find cures. If you’d like to support the event by participating or donating to the cause, click here for the link.